REMD Biotherapeutics IPO

remdbio.com

REMD Biotherapeutics is a biotech company focused on creating and developing innovative protein-based therapies to treat metabolic diseases and other serious illnesses.

Founded2011
Register for Details

For more details on financing and valuation for REMD Biotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

REMD Biotherapeutics Ticker Symbol

REMD Biotherapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

REMD Biotherapeutics Stock Price

The stock price for REMD Biotherapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Other companies like REMD Biotherapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector